Literature DB >> 9274521

The interactions of APC, E-cadherin and beta-catenin in tumour development and progression.

M Ilyas1, I P Tomlinson.   

Abstract

Much progress has been made in identifying genes mutated during the development of colorectal carcinoma. Mutation of the APC gene in particular appears to be fundamental for colorectal tumour initiation. In contrast, loss of expression of E-cadherin appears to be a late event, which may be important in the development of invasion. Recent clarification of the function of APC, however, has shown that it exists in equilibrium with beta-catenin and E-cadherin. This review discusses the function of these molecules, their interactions, and how APC mutations may alter the equilibrium with beta-catenin and E-cadherin. It is argued that these changes cause aberrant architectural development of tissue, which results in loss of growth control. It is this escape from growth control, rather than acquisition of cell-autonomous growth, which results in the initial development of adenomas. The role of the E-cadherin-catenin unit in colorectal tumour invasion is discussed and the evidence is reviewed for the involvement of APC and E-cadherin in tumours arising from non-intestinal epithelia.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9274521     DOI: 10.1002/(SICI)1096-9896(199706)182:2<128::AID-PATH839>3.0.CO;2-Q

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  31 in total

Review 1.  The role of the E-cadherin complex in gastrointestinal cell differentiation.

Authors:  R Del Buono; M Pignatelli
Journal:  Cell Prolif       Date:  1999 Apr-Jun       Impact factor: 6.831

2.  An F-box protein, FWD1, mediates ubiquitin-dependent proteolysis of beta-catenin.

Authors:  M Kitagawa; S Hatakeyama; M Shirane; M Matsumoto; N Ishida; K Hattori; I Nakamichi; A Kikuchi; K Nakayama; K Nakayama
Journal:  EMBO J       Date:  1999-05-04       Impact factor: 11.598

3.  Prognostic relevance of β-catenin expression in T2-3N0M0 esophageal squamous cell carcinoma.

Authors:  Dong-Rong Situ; Yi Hu; Zhi-Hua Zhu; Jian Wang; Hao Long; Tie-Hua Rong
Journal:  World J Gastroenterol       Date:  2010-11-07       Impact factor: 5.742

4.  Proliferation, but not apoptosis, is associated with distinct beta-catenin expression patterns in non-small-cell lung carcinomas: relationship with adenomatous polyposis coli and G(1)-to S-phase cell-cycle regulators.

Authors:  Athamassios Kotsinas; Konstantinos Evangelou; Panayotis Zacharatos; Christos Kittas; Vassilis G Gorgoulis
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

Review 5.  The molecular biology of colorectal cancer development and the associated genetic events.

Authors:  R M Navaratnam; J Chowaniec; M C Winslet
Journal:  Ann R Coll Surg Engl       Date:  1999-09       Impact factor: 1.891

Review 6.  Role of retinoids in the prevention and treatment of colorectal cancer.

Authors:  Catherine C Applegate; Michelle A Lane
Journal:  World J Gastrointest Oncol       Date:  2015-10-15

7.  Expression of e-cadherin and beta-catenin in human esophageal squamous cell carcinoma: relationships with prognosis.

Authors:  Xi-Jiang Zhao; Hui Li; Hua Chen; Yan-Xue Liu; Li-Hua Zhang; Su-Xiang Liu; Qing-Lai Feng
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

8.  Wnt/beta-catenin/Tcf signaling pathway activation in malignant progression of rat gliomas induced by transplacental N-ethyl-N-nitrosourea exposure.

Authors:  Gangadhara Reddy Sareddy; Sundaram Challa; Manas Panigrahi; Phanithi Prakash Babu
Journal:  Neurochem Res       Date:  2009-01-16       Impact factor: 3.996

9.  Aberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinoma.

Authors:  Bin Yang; Mingzhou Guo; James G Herman; Douglas P Clark
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

10.  α-Actinin-4 induces the epithelial-to-mesenchymal transition and tumorigenesis via regulation of Snail expression and β-catenin stabilization in cervical cancer.

Authors:  H-T An; S Yoo; J Ko
Journal:  Oncogene       Date:  2016-04-11       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.